Frost & Sullivan Research Service   Published: 9 Feb 2011
Pharmaceutical Industry in Ghana and Nigeria
  SERVICE HOMEPAGE
RESEARCH OVERVIEW LIST OF FIGURES TABLE OF CONTENTS
ORDERING INFORMATION FURTHER INFORMATION
   Research Overview
 

This Frost & Sullivan research service titled Pharmaceutical Industry in Ghana and Nigeria provides insight into the current market value, projected future growth and current trends in the West African pharmaceutical market and highlights key opportunities in each therapeutic segment. In this research, Frost & Sullivan's expert analysts thoroughly examine the following therapeutic segments: anti-infectives, cardiovascular, diabetes, respiratory, oncology and central nervous system.

This analysis is available through our Pharmaceuticals & Biotechnology Growth Partnership Services programme. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services programme ensures that you and your Growth Team™ are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth. For more information on this custom subscription service, please click here.

Market Overview

Increase in Non-communicable Diseases creates Lucrative Market Opportunities for Generics

With the adoption of a more western lifestyle characterised by less healthy diets and more sedentary activities across West African countries like Nigeria and Ghana, the incidence of non-communicable diseases, particularly hypertension and diabetes, have increased. As the demand for chronic medicines for these conditions surges, lucrative market opportunities, particularly in the generic market, have opened up. “The dual burden of communicable and non-communicable diseases in Ghana and Nigeria is the main driver for growth of the pharmaceutical industry in the region,” notes the analyst of this research. “Second and third, only to anti-infectives, in terms of contribution to the 2009 annual pharmaceutical industry revenues in Ghana and Nigeria were medicines for cardiovascular conditions and diabetes.”

Treatment for diabetes and cardiovascular conditions such as hypertension is typically chronic, thereby creating a continual demand for diabetes and hypertension medicines. Several foreign generic companies have entered the West African market and more local manufacturers are focussing on medicines for hypertension and diabetes.

Focus on Product Quality to Help Foster Brand Loyalty and Obviate Price Sensitivity of Consumers

As the major proportion of consumers in Ghana and Nigeria are price-sensitive, competition with low-cost Asian generics is a challenge for the majority of participants in the market. The cost of conducting business for local manufacturers is particularly high. “Price is an important purchasing criterion for the Ghana National Health Insurance (NHI) which covers 66.4 per cent of the population in Ghana and the NHI will only pay for generics,” explains the analyst. “Additionally, government tenders in both countries are awarded mainly on the basis of price.”

It is important that companies in this market identify their target customers and differentiate themselves accordingly. Although the majority of consumers in the region are price sensitive, several others are brand loyal and willing to pay the cost for their preferred brands. “Although pricing is a major factor to success in Ghana and Nigeria, other factors such as having good quality products, having a robust distribution network, good marketing strategies and brand recognition are equally important,” concludes the analyst. “Pharmaceutical companies can leverage these factors to attain a competitive position in the market.”

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following therapeutic segments in this research:

  • Anti-infectives
  • Cardiovascular
  • Diabetes
  • Respiratory
  • Oncology
  • Central nervous system

By Country:

  • Nigeria
  • Ghana

Frost & Sullivan Growth Partnership Services

Frost & Sullivan's Growth Partnership Services empower companies to accelerate their growth by achieving top-line improvements and bottom-line results. This is accomplished by helping our clients execute successful growth strategies and providing their Growth Teams™ with the skills, know-how, and tools to generate growth opportunities, evaluate these opportunities to create a growth pipeline, and implement a growth strategy to deliver measurable business results.

Our growth solutions support the entire growth process:

TEAM Research

is a program that furnishes clients with access to market research, competitive intelligence, financial benchmarking, and market strategies and analysis, and provides access to industry experts to aid in generating growth opportunities.

Growth Consulting Services

unite clients with our industry experts to evaluate opportunities and develop customised strategies and business plans to drive top-line revenue and margin growth.

Growth Team Membership™

is a career-focused offering that was developed to address the unique challenges that senior executives face when implementing strategies to achieve aggressive corporate growth targets.

  Table Of Contents

1. Executive Summary

 

2. Research Aim and Objectives

 

3. Research Scope, Definitions and Exchange Rates

 

4. Research Methodology

 

5. Pharmaceutical Industry; Ghana and Nigeria

   5.1 Introduction

   5.2 Market Engineering Measurements

   5.3 Industry Challenges

   5.4 Market Drivers

   5.5 Market Restraints

   5.6 Total Pharmaceutical Industry Revenue Forecast

   5.7 Public and Private Sector Revenue Forecasts

   5.8 Segmental Revenue Forecasts

   5.9 Revenue Forecasts by Therapeutic Segment

   5.10 Future Growth Potential by Therapeutic Segment

   5.11 Porter’s Five Forces Analysis

   5.12 Strengths, Weaknesses, Opportunities, Threats Analysis

   5.13 Key Success Factors

 

6. Ghanaian Pharmaceutical Industry

   6.1 Country Overview

   6.2 Healthcare Overview

   6.3 Pharmaceutical Industry Overview

   6.4 Market Engineering Measurements

   6.5 Total Pharmaceutical Industry Revenue Forecast

   6.6 Growth of Key Segments

   6.7 Revenue Forecasts by Therapeutic Segment

   6.8 Competitive Structure

   6.9 Local Manufacturing

   6.10 Competitor Analysis

   6.11 Competitor Profiles

   6.12 Opportunity Analysis

 

7. Nigerian Pharmaceutical Industry

   7.1 Country Overview

   7.2 Healthcare Overview

   7.3 Pharmaceutical Industry Overview

   7.4 Market Engineering Measurements

   7.5 Total Pharmaceutical Industry Revenue Forecast

   7.6 Growth of Key Segments

   7.7 Revenue Forecasts by Therapeutic Segment

   7.8 Competitive Structure

   7.9 Local Manufacturing

   7.10 Competitor Analysis

   7.11 Competitor Profiles

   7.12 Opportunity Analysis

 

8. Conclusions

 

9. About Frost & Sullivan



   List of Figures
 
  • Pharmaceutical Industry: Market Engineering Measurements (Ghana; Nigeria), 2009
  • Pharmaceutical Industry: Impact of Top Industry Challenges (Ghana; Nigeria), 2010-2016
  • Pharmaceutical Industry: Market Drivers Ranked in Order of Impact (Ghana; Nigeria), 2010-2016
  • Pharmaceutical Industry: Market Restraints Ranked in Order of Impact (Ghana; Nigeria), 2009-2016
  • Pharmaceutical Industry: Revenue Forecasts (Ghana; Nigeria), 2009-2016 Pharmaceutical Industry: Growth Potential (Ghana; Nigeria) 2009-2016
  • Pharmaceutical Industry: Porter Analysis (Ghana; Nigeria), 2009
  • Pharmaceutical Industry: Key Success Factors (Ghana; Nigeria), 2009-2016
  • Pharmaceutical Industry: Mortality and Burden of Disease (Ghana), 2009
  • Pharmaceutical Industry: Healthcare Industry Structure (Ghana), 2009
  • Pharmaceutical Industry: Regulatory Bodies (Ghana), 2009
  • Pharmaceutical Industry: Market Size by Segmentation (Ghana), 2009
  • Pharmaceutical Industry: Market Engineering Measurements (Ghana), 2009
  • Pharmaceutical Industry: Revenue Forecasts (Ghana), 2009-2016
  • Pharmaceutical Industry: Competitive Structure (Ghana), 2009
  • Pharmaceutical Industry: Key Local Manufacturers (Ghana), 2009
  • Pharmaceutical Industry: Key Generic Market Suppliers (Ghana), 2009
  • Pharmaceutical Industry: Key Branded Market Suppliers (Ghana), 2009
  • Pharmaceutical Industry: Opportunities in Therapeutic Segments (Ghana), 2009
  • Pharmaceutical Industry: Mortality and Burden of Disease (Nigeria), 2009
  • Pharmaceutical Industry: Public Health Structure (Nigeria), 2009
  • Pharmaceutical Industry: Selected Healthcare Personnel by Discipline (Nigeria), 2007
  • Pharmaceutical Industry: Regulatory Bodies (Nigeria), 2009
  • Pharmaceutical Industry: Market Size by Segmentation (Nigeria), 2009
  • Pharmaceutical Industry: Market Engineering Measurements (Nigeria), 2009
  • Pharmaceutical Industry: Revenue Forecasts (Nigeria), 2009-2016
  • Pharmaceutical Industry: Competitive Structure (Nigeria), 2009
  • Pharmaceutical Industry: Key Local Manufacturers (Nigeria), 2009
  • Pharmaceutical Industry: Key Generic Market Suppliers (Nigeria), 2009
  • Pharmaceutical Industry: Key Branded Market Suppliers (Nigeria), 2009
  • Pharmaceutical Industry: Opportunities in Therapeutic Segments (Nigeria), 2009
  • Pharmaceutical Industry: Pharmaceutical Industry Size and Growth (Ghana; Nigeria), 2009
  • Pharmaceutical Industry: Market Size and Anticipated Growth per Therapeutic Segment (Ghana; Nigeria), 2009

LOC

  • Pharmaceutical Industry: Country Contribution to Total Industry Value (Ghana; Nigeria), 2009-2016
  • Pharmaceutical Industry: Revenue Forecasts (Ghana; Nigeria), 2009-2016
  • Pharmaceutical Industry: Revenue Forecasts by Country (Ghana; Nigeria), 2009-2016
  • Pharmaceutical Industry: Private Sector Contribution by Country (Ghana; Nigeria), 2009
  • Pharmaceutical Industry: Public Sector Contribution by Country (Ghana; Nigeria), 2009
  • Pharmaceutical Industry: Revenue Forecasts by Segment (Ghana; Nigeria), 2009-2016
  • Pharmaceutical Industry: Percentage Revenue Contribution by Segment (Ghana; Nigeria), 2009-2016
  • Pharmaceutical Industry: Percentage Country Contribution towards Segment (Ghana; Nigeria), 2009
  • Pharmaceutical Industry: Percentage Country Contribution towards Segment (Ghana; Nigeria), 2016
  • Pharmaceutical Industry: Revenue Forecasts by Therapeutic Segment (Ghana; Nigeria), 2009-2016
  • Pharmaceutical Industry: Percentage Revenue Contribution by Therapeutic Segment (Ghana; Nigeria), 2009-2016
  • Pharmaceutical Industry: Number of Hospital Beds by Ownership (Ghana), 2008
  • Pharmaceutical Industry: Sources of Healthcare Funding (Ghana), 2009, 2010
  • Pharmaceutical Industry: Revenue Forecasts (Ghana), 2009-2016
  • Pharmaceutical Industry: Percentage Revenue Contribution of Key Segments (Ghana), 2009-2016
  • Pharmaceutical Industry: Revenue Growth of Key Segments (Ghana), 2009-2016
  • Pharmaceutical Industry: Therapeutic Segments Revenue Forecasts (Ghana), 2009-2016
  • Pharmaceutical Industry: Revenue Contribution of the Cardiovascular Market to the Total Market (Ghana), 2009-2016
  • Pharmaceutical Industry: Revenue Contribution of the Diabetes Market to Total Market (Ghana), 2009-2016
  • Pharmaceutical Industry: Revenue Contribution of the Respiratory Market to the Total Market (Ghana), 2009-2016
  • Pharmaceutical Industry: Revenue Contribution of the CNS Market to the Total Market (Ghana), 2009-2016
  • Pharmaceutical Industry: Revenue Contribution of the Oncology Market to the Total Market (Ghana), 2009-2016
  • Pharmaceutical Industry: Healthcare Facilities by Status (Nigeria), 2009
  • Pharmaceutical Industry: Revenue Forecasts (Nigeria), 2009-2016
  • Pharmaceutical Industry: Percentage Revenue Contribution by Segments (Nigeria), 2009-2016
  • Pharmaceutical Industry: Revenue Forecasts by Segments (Nigeria), 2009-2016
  • Pharmaceutical Industry: Therapeutic Segments Revenue Forecasts (Nigeria), 2009-2016
  • Pharmaceutical Industry: Revenue Contribution of the Cardiovascular Market to the Total Market (Nigeria), 2009-2016
  • Pharmaceutical Industry: Revenue Contribution of the Diabetes Market to Total Market (Nigeria), 2009-2016
  • Pharmaceutical Industry: Revenue Contribution of the Respiratory Market to the Total Market (Nigeria), 2009-2016
  • Pharmaceutical Industry: Revenue Contribution of the CNS Market to the Total Market (Nigeria), 2009-2016
  • Pharmaceutical Industry: Revenue Contribution of the Oncology Market to the Total Market (Nigeria), 2009-2016
  More Information
Please print out this form, complete your details and fax it to Frost & Sullivan:
Latin & North America:
Frost & Sullivan
Sales Department
7550 West Interstate 10
Suite 400
San Antonio
Texas 78229-5616. USA
Fax: 888.690.3329
Asia Pacific:
Frost & Sullivan
Sales Department
100 Beach Road
#29-01/11, Shaw Tower
Singapore 189702
SINGAPORE
Fax: +65 68900988
EMEA:
Frost & Sullivan
Sales Department
Sullivan House
4 Grosvenor Gardens
London SW1W 0DH. UK
Fax: +44(0) 1865 389 515
SERVICE INQUIRY


I would like information on:
Pharmaceutical Industry in Ghana and Nigeria (M65E-01-00-00-00)

YOUR DETAILS

Name Address
Title
Company
Telephone State/Province
Fax Zip/Postal Code
Email Country
Select the markets that interest you Tell us the services that interest you
Aerospace & Defense
Automotive & Transportation
Business & Financial Services
Career Research
Chemicals, Materials & Foods
Consumer Products
Education
Electronics and Security
Energy & Power Systems
Environment & Building Technologies
Healthcare
Industrial Automation
Information & Communication Tech.
Measurement & Instrumentation
Metals & Minerals
 
Growth Partnership Services
Growth Team Membership
Growth Strategy Dialogue
Growth Consulting
Growth Workshops
Events
Corporate Training & Development
Best Practices Research
Technical Research
Econometric Research
Market Engineering Research
Customer Research
Financial Benchmarking & Analysis
Stratecast: Telecoms Strategic Forecasting
Career Opportunities
Press Support Services
Comments: (For instance 'Please send me more information on...')

  Further Information

Enquiries from:
Africa:
Tel:+27 21 680 3260
Email: enquiries@frost.com

Enquiries from:
Asia Pacific:
Tel: +65 68900999
Email: apacfrost@frost.com
 
Enquiries from:
Europe:
Tel: +44 (0) 20 7343 8383
Email: enquiries@frost.com
Enquiries from:
Latin America:
Tel: +54 11 4777 1550
Email: myfrost.la@frost.com
 

Enquiries from:
Middle East and North Africa:
Tel: +971.4.4331.893
Email: meenquiries@frost.com

Enquiries from:
North America:
Tel:+1.877.GO.FROST (463.7678)
Email: enquiries@frost.com
 

Enquiries from:
South Asia:
Tel: +91 (0) 22 6160 6666
Email: safrost@frost.com




 
For a full list of our offices click here.
 
Conseq